<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15">
 <label>15</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Perez-Molina</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Martinez</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Blasco</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>Arribas</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Domingo</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Iribarren</surname>
    <given-names>JA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults</article-title>
  <source>Enferm Infecc Microbiol Clin</source>
  <year>2019</year>
  <date-in-citation content-type="access-date">Feb 3, 2020</date-in-citation>
  <volume>37</volume>
  <issue>3</issue>
  <fpage>151</fpage>
  <lpage>159</lpage>
  <comment>Available from: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.eimc.2018.04.010" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/ 10.1016/j.eimc.2018.04.010</ext-link>
  </comment>
  <pub-id pub-id-type="pmid">29884455</pub-id>
 </element-citation>
</ref>
